Novavax Inc (NVAX)
9.35
-0.26
(-2.71%)
USD |
NASDAQ |
Nov 01, 16:00
9.42
+0.07
(+0.75%)
After-Hours: 20:00
Novavax Profit Margin (Quarterly): 39.08% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 39.08% |
| March 31, 2024 | -157.2% |
| December 31, 2023 | -70.40% |
| September 30, 2023 | -592.7% |
| June 30, 2023 | 13.67% |
| March 31, 2023 | |
| December 31, 2022 | -63.32% |
| September 30, 2022 | -26.84% |
| June 30, 2022 | -274.6% |
| March 31, 2022 | 33.64% |
| December 31, 2021 | |
| September 30, 2021 | -180.3% |
| June 30, 2021 | -118.2% |
| March 31, 2021 | -49.80% |
| December 31, 2020 | |
| September 30, 2020 | -125.7% |
| June 30, 2020 | -49.30% |
| March 31, 2020 | -765.9% |
| December 31, 2019 | -361.0% |
| September 30, 2019 | -719.7% |
| June 30, 2019 | -1.18K% |
| March 31, 2019 | -1.09K% |
| December 31, 2018 | -805.2% |
| September 30, 2018 | -576.2% |
| June 30, 2018 | -413.0% |
| Date | Value |
|---|---|
| March 31, 2018 | -480.2% |
| December 31, 2017 | -488.3% |
| September 30, 2017 | -534.1% |
| June 30, 2017 | -660.5% |
| March 31, 2017 | -772.1% |
| December 31, 2016 | -1.06K% |
| September 30, 2016 | -2.05K% |
| June 30, 2016 | -3.17K% |
| March 31, 2016 | -1.83K% |
| December 31, 2015 | -1.35K% |
| September 30, 2015 | -507.6% |
| June 30, 2015 | -147.5% |
| March 31, 2015 | -246.7% |
| December 31, 2014 | -469.2% |
| September 30, 2014 | -240.2% |
| June 30, 2014 | -216.3% |
| March 31, 2014 | -185.1% |
| December 31, 2013 | -160.7% |
| September 30, 2013 | -318.6% |
| June 30, 2013 | -357.8% |
| March 31, 2013 | -260.8% |
| December 31, 2012 | -176.0% |
| September 30, 2012 | -125.2% |
| June 30, 2012 | -83.35% |
| March 31, 2012 | -158.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-765.9%
Minimum
Mar 2020
39.08%
Maximum
Jun 2024
-171.8%
Average
-94.31%
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 25.22% |
| Moderna Inc | -578.7% |
| BioCryst Pharmaceuticals Inc | -11.59% |
| Eli Lilly and Co | 8.48% |
| AIM ImmunoTech Inc | -3.67K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -17.71% |
| Gross Profit Margin (Quarterly) | 88.87% |
| Operating Margin (Quarterly) | 38.75% |
| Return on Net Operating Assets | -36.48% |